Analysis by number of people who received a prescription
60 Day Prescribing Blog #2
60 Day Prescribing Blog #2
For most medicines in Stage 1, 60-day prescriptions accounted for just under a quarter of all scripts after the first year. Uptake of 60-day prescribing for dermatologicals was faster, reaching almost 40% by the end of the first year. However, dermatologicals make up a small proportion of total Stage 1 dispensing. The proportion of people receiving a 60-day prescription for the first time (“incident 60-day prescriptions”) for dermatologicals was about 12% throughout the study period, showing that many people were newly prescribed 60-day prescriptions each month. Incident 60-day prescriptions per month were lower for all the other types of medicines (ATC1 classifications).
First time (incident) 60-day dispensings for cardiovascular medicines peaked 3 months into the policy at 6% of the total dispensing for Stage 1 cardiovascular medicines, before halving to 3% by the end of the first year.
The peak suggests a backlog of people on long-term therapy switching from 30-day to 60-day prescribing.
The increasing proportion of individuals continuing on 60-day prescriptions signals that people are staying on 60DD once they start.
Of people who received their first 60-day prescription each month, about:
We thank the Australian Government Services Australia for providing the data.